Chemed (CHE) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Chemed Revenue Highlights

Latest Revenue (Y)

$2.53B

Latest Revenue (Q)

$673.25M

Main Segment (Y)

Segment Vitas

Chemed Revenue by Period

Chemed Revenue by Year

Date	Revenue	Change
2025-12-31	$2.53B	4.06%
2024-12-31	$2.43B	7.37%
2023-12-31	$2.26B	6.06%
2022-12-31	$2.13B	-0.20%
2021-12-31	$2.14B	2.87%
2020-12-31	$2.08B	7.27%
2019-12-31	$1.94B	8.75%
2018-12-31	$1.78B	6.96%
2017-12-31	$1.67B	5.70%
2016-12-31	$1.58B	2.17%
2015-12-31	$1.54B	5.98%
2014-12-31	$1.46B	3.04%
2013-12-31	$1.41B	-1.17%
2012-12-31	$1.43B	5.46%
2011-12-31	$1.36B	5.89%
2010-12-31	$1.28B	7.59%
2009-12-31	$1.19B	3.59%
2008-12-31	$1.15B	4.44%
2007-12-31	$1.10B	8.00%
2006-12-31	$1.02B	11.20%
2005-12-31	$915.97M	24.64%
2004-12-31	$734.88M	181.80%
2003-12-31	$260.78M	2.79%
2002-12-31	$253.69M	-24.92%
2001-12-31	$337.91M	-4.90%
2000-12-31	$355.31M	-21.67%
1999-12-31	$453.60M	18.96%
1998-12-31	$381.30M	11.59%
1997-12-31	$341.70M	13.45%
1996-12-31	$301.20M	-56.92%
1995-12-31	$699.20M	8.40%
1994-12-31	$645.00M	22.83%
1993-12-31	$525.10M	-

Chemed generated $2.53B in revenue during NA 2025, up 4.06% compared to the previous quarter, and up 121.66% compared to the same period a year ago.

Chemed Revenue by Quarter

Date	Revenue	Change
2026-06-30	$673.25M	2.39%
2026-03-31	$657.51M	2.84%
2025-12-31	$639.34M	2.31%
2025-09-30	$624.90M	0.99%
2025-06-30	$618.80M	-4.35%
2025-03-31	$646.94M	1.09%
2024-12-31	$639.99M	5.58%
2024-09-30	$606.18M	1.73%
2024-06-30	$595.88M	1.13%
2024-03-31	$589.23M	0.57%
2023-12-31	$585.91M	3.79%
2023-09-30	$564.53M	1.93%
2023-06-30	$553.82M	-1.13%
2023-03-31	$560.16M	2.47%
2022-12-31	$546.65M	3.83%
2022-09-30	$526.47M	-0.91%
2022-06-30	$531.29M	0.14%
2022-03-31	$530.55M	-1.93%
2021-12-31	$540.98M	0.43%
2021-09-30	$538.67M	1.20%
2021-06-30	$532.26M	0.93%
2021-03-31	$527.36M	-1.11%
2020-12-31	$533.29M	0.94%
2020-09-30	$528.30M	5.20%
2020-06-30	$502.20M	-2.64%
2020-03-31	$515.80M	-1.25%
2019-12-31	$522.32M	8.68%
2019-09-30	$480.61M	1.48%
2019-06-30	$473.58M	2.50%
2019-03-31	$462.03M	0.99%
2018-12-31	$457.51M	3.01%
2018-09-30	$444.15M	0.53%
2018-06-30	$441.81M	0.60%
2018-03-31	$439.18M	2.53%
2017-12-31	$428.36M	2.61%
2017-09-30	$417.44M	0.57%
2017-06-30	$415.06M	2.27%
2017-03-31	$405.86M	0.59%
2016-12-31	$403.48M	2.77%
2016-09-30	$392.61M	0.56%
2016-06-30	$390.41M	0.01%
2016-03-31	$390.39M	-2.06%
2015-12-31	$398.59M	3.20%
2015-09-30	$386.23M	1.13%
2015-06-30	$381.92M	1.40%
2015-03-31	$376.65M	-0.73%
2014-12-31	$379.41M	5.87%
2014-09-30	$358.39M	-0.50%
2014-06-30	$360.18M	0.53%
2014-03-31	$358.30M	2.78%
2013-12-31	$348.60M	2.26%
2013-09-30	$340.89M	-4.57%
2013-06-30	$357.20M	-2.58%
2013-03-31	$366.64M	-0.53%
2012-12-31	$368.58M	4.01%
2012-09-30	$354.35M	0.05%
2012-06-30	$354.17M	0.35%
2012-03-31	$352.94M	0.77%
2011-12-31	$350.25M	2.58%
2011-09-30	$341.44M	2.42%
2011-06-30	$333.36M	0.74%
2011-03-31	$330.92M	-1.60%
2010-12-31	$336.29M	4.94%
2010-09-30	$320.45M	1.73%
2010-06-30	$315.00M	2.00%
2010-03-31	$308.81M	1.83%
2009-12-31	$303.25M	2.17%
2009-09-30	$296.79M	0.52%
2009-06-30	$295.25M	0.11%
2009-03-31	$294.94M	0.94%
2008-12-31	$292.20M	1.35%
2008-09-30	$288.31M	1.82%
2008-06-30	$283.16M	-0.74%
2008-03-31	$285.27M	-0.16%
2007-12-31	$285.73M	-

Chemed generated $673.25M in revenue during Q2 2026, up 2.39% compared to the previous quarter, and up 104.07% compared to the same period a year ago.

Chemed Revenue Breakdown

Chemed Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Segment Roto Rooter	$937.92M	-	-	-	-
Segment Vitas	$1.69B	-	-	-	-
All Other Revenue Self Pay Respite Care Ect.	-	$19.45M	$13.58M	$12.44M	$12.14M
Routine Home Care	-	$1.33B	$1.14B	-	-
Inpatient Care	-	$120.60M	$112.42M	-	-
Continuous Care	-	$99.75M	$85.67M	-	-
Care Services Total	-	$1.55B	$1.33B	-	-

Chemed's latest annual revenue breakdown by segment (product or service), as of Dec 25: Segment Vitas (64.27%), and Segment Roto Rooter (35.73%).

Quarterly Revenue by Product

Product/Service	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
Segment Roto Rooter	$236.95M	$245.28M	$231.59M	$226.48M	$230.98M	$248.87M	$230.68M	$224.84M	-	-	-	-	-	-	-	-	-	-	-	-
Segment Vitas	$452.62M	$430.73M	$429.85M	$421.26M	$420.45M	$415.57M	$322.76M	-	-	-	-	-	-	-	-	-	-	-	-	-
All Other Revenue Self Pay Respite Care Ect.	-	-	-	-	-	-	$5.56M	$5.08M	$4.73M	$4.08M	$3.85M	$3.56M	$3.15M	$3.02M	$2.98M	$3.24M	$3.21M	$3.01M	-	-
Care Services Total	-	-	-	-	-	-	$415.26M	$394.07M	$378.18M	$359.33M	$997.29M	$337.24M	-	-	-	-	-	-	-	-
Continuous Care	-	-	-	-	-	-	$25.45M	$25.80M	$24.33M	$24.17M	$63.64M	$22.03M	-	-	-	-	-	-	-	-
Inpatient Care	-	-	-	-	-	-	$31.31M	$29.92M	$29.07M	$30.30M	$84.60M	$27.82M	-	-	-	-	-	-	-	-
Routine Home Care	-	-	-	-	-	-	$358.51M	$338.34M	$324.78M	$304.86M	$849.05M	$287.39M	-	-	-	-	-	-	-	-

Chemed's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: Segment Vitas (65.64%), and Segment Roto Rooter (34.36%).

Chemed Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
DVA	DaVita	$13.64B	$3.55B
HSIC	Henry Schein	$13.18B	$3.37B
BTSG	BrightSpring Health Services	$12.91B	$3.87B
OPCH	Option Care Health	$5.65B	$1.44B
ATR	AptarGroup	$3.78B	$1.03B
BRKR	Bruker	$3.44B	$838.50M
CHE	Chemed	$2.53B	$673.25M
TFX	Teleflex	$1.99B	$570.33M
STVN	Stevanato Group S.p.A.	$1.06B	$237.38M
MTSR	Metsera	-	-

CHE Revenue FAQ

What is Chemed’s yearly revenue?

Chemed's yearly revenue for 2025 was $2.53B, representing an increase of 4.06% compared to 2024. The company's yearly revenue for 2024 was $2.43B, representing an increase of 7.37% compared to 2023. CHE's yearly revenue for 2023 was $2.26B, representing an increase of 6.06% compared to 2022.

What is Chemed’s quarterly revenue?

Chemed's quarterly revenue for Q2 2026 was $673.25M, a 2.39% increase from the previous quarter (Q1 2026), and a 8.80% increase year-over-year (Q2 2025). The company's quarterly revenue for Q1 2026 was $657.51M, a 2.84% increase from the previous quarter (Q4 2025), and a 1.63% increase year-over-year (Q1 2025). CHE's quarterly revenue for Q4 2025 was $639.34M, a 2.31% increase from the previous quarter (Q3 2025), and a -0.10% decrease year-over-year (Q4 2024).

What is Chemed’s revenue growth rate?

Chemed's revenue growth rate for the last 3 years (2023-2025) was 11.73%, and for the last 5 years (2021-2025) was 18.26%.

What are Chemed’s revenue streams?

Chemed's revenue streams in c 25 are Segment Roto Rooter, and Segment Vitas. Segment Roto Rooter generated $937.92M in revenue, accounting 35.73% of the company's total revenue Segment Vitas generated $1.69B in revenue, accounting 64.27% of the company's total revenue

What is Chemed’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Chemed was Segment Vitas. This segment made a revenue of $1.69B, representing 64.27% of the company's total revenue.